Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face
Clinical trial NCT04210258 · COMPLETED
Trial details
- NCT number
- NCT04210258
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-12-27
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.